BPGBio Inc
- Biotech or pharma, therapeutic R&D
BPGbio is a leading AI-powered clinical stage biopharma focused on mitochondrial biology and protein homeostasis. The company has a deep pipeline of AI-developed therapeutics spanning oncology, rare disease and neurology, including several in clinical development. BPGbio’s novel approach is underpinned by NAi, its proprietary Interrogative Biology Platform that leverages patient biology for solving large-scale biology challenges. Headquartered in greater Boston, the company is at the forefront of a new era in medicine, combining biology, multi-modal data, and AI to transform the way we understand, diagnose, and treat disease.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}